Crane Co
9 nominees · 3 ballot items.
Three proposals: (1) election of nine directors for one-year terms; (2) ratification of Deloitte & Touche LLP as independent auditors for 2026; and (3) a non-binding advisory (say-on-pay) vote to approve the 2025 compensation of the named executive officers.
Follow how the vote landed and what changed on Crane Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect nine directors (Martin R. Benante, Sanjay Kapoor, Ronald C. Lindsay, Susan D. Lynch, Ellen McClain, Charles G. McClure, Jr., Max H. Mitchell, Jennifer M. Pollino, and James L. L. Tullis) to serve one-year terms until the 2027 annual meeting.
- 2
Ratification of the Selection of Deloitte & Touche LLP as Independent Auditors for 2026
ManagementBoard: FORRatify the Audit Committee’s selection of Deloitte & Touche LLP as Crane Company’s independent registered public accounting firm for 2026.
- 3
Advisory Vote to Approve the Compensation of Named Executive Officers (Say-on-Pay
ManagementBoard: FORA non-binding advisory vote requesting stockholder approval of the compensation paid to Crane Company’s named executive officers for 2025.
More detail
This proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s disclosed 2025 executive compensation. Management seeks shareholder approval to validate its compensation framework, which emphasizes pay-for-performance through a mix of annual cash incentives tied to adjusted EPS and adjusted free cash flow and long-term equity awards (55% PRSUs tied to relative TSR, 25% stock options, 20% time-based RSUs for the CEO). The Compensation Committee sets targets against peer and survey data and retains an independent compensation consultant; the Committee also conducts pay-for-performance and risk assessments and has clawback and anti-hedging policies. The Company highlights strong 2025 operating performance, record segment margins, strategic acquisitions (Panametrics/Druck/Reuter‑Stokes and optek‑Danulat), and an executed CEO succession plan as context for awards and payouts. Because the vote is advisory, management cannot compel a specific outcome but will consider the vote when making future compensation decisions; the Board explicitly states it will give due consideration to stockholder opinions. The non-binding nature and the Company’s prior say-on-pay result (over 97% support in 2025) reduce the risk of forced changes, but a negative vote could prompt re-evaluation of pay design, target setting, or disclosure. Key governance features supporting management’s recommendation include high proportions of performance-based pay (86% for the CEO), rigorous peer benchmarking, stock ownership guidelines, and a revised clawback policy consistent with SEC and NYSE rules. Investors evaluating the proposal should weigh the Company’s recent financial and strategic performance, the alignment of pay metrics with long-term value creation (TSR, adjusted EPS, free cash flow), and the potential impact of succession and acquisition activity on compensation levels and retention needs.
Nominees on the ballot9
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.7% | 2,721,024 | $465M |
| 2 | Capital World Investors | 4.1% | 2,388,939 | $409M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 2,198,737 | $376M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6% | 2,101,208 | $359M |
| 5 | FMR LLC | 3.2% | 1,819,243 | $311M |
| 6 | BlackRock, Inc. | 2.6% | 1,494,210 | $256M |
| 7 | STATE STREET CORP | 2.6% | 1,486,080 | $254M |
| 8 | Capital International Investors | 1.9% | 1,073,740 | $184M |
| 9 | GAMCO INVESTORS, INC. ET AL | 1.7% | 998,391 | $171M |
| 10 | AQR CAPITAL MANAGEMENT LLC | 1.7% | 971,056 | $160M |
Other Industrials sector meetings6
Upcoming shareholder meetings at Crane Co’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Crane Co 2026 annual meeting?
- Crane Co (CR) holds its 2026 annual shareholder meeting on Monday, April 27, 2026.
- What is the record date for the Crane Co 2026 meeting?
- The record date for the Crane Co 2026 meeting is Wednesday, March 4, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Crane Co's 2026 meeting?
- The board is presenting 9 director nominees at the Crane Co 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Crane Co 2026 meeting?
- Shareholders will vote on 3 proposals at the Crane Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.